Clinical Trial Update: Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ketorolac to ibuprofen for painful episodes in sickle cell disease was terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Ibuprofen (IBUPROFEN)
• Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Hematologic Diseases, Anemia, Sickle Cell | Phase 4 | Status: TERMINATED | Results posted: 2020-10-08